Home Cart 0 Sign in  

[ CAS No. 98232-51-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 98232-51-0
Chemical Structure| 98232-51-0
Structure of 98232-51-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 98232-51-0 ]

Related Doc. of [ 98232-51-0 ]

Alternatived Products of [ 98232-51-0 ]

Product Details of [ 98232-51-0 ]

CAS No. :98232-51-0 MDL No. :MFCD19285566
Formula : C11H12O3 Boiling Point : -
Linear Structure Formula :- InChI Key :JZQSNXSAQQFZFS-UHFFFAOYSA-N
M.W : 192.21 Pubchem ID :12236545
Synonyms :

Calculated chemistry of [ 98232-51-0 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.36
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 52.31
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.27 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.2
Log Po/w (XLOGP3) : 1.7
Log Po/w (WLOGP) : 2.05
Log Po/w (MLOGP) : 1.03
Log Po/w (SILICOS-IT) : 2.63
Consensus Log Po/w : 1.92

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.35
Solubility : 0.851 mg/ml ; 0.00443 mol/l
Class : Soluble
Log S (Ali) : -2.06
Solubility : 1.67 mg/ml ; 0.00868 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.27
Solubility : 0.104 mg/ml ; 0.000542 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.41

Safety of [ 98232-51-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 98232-51-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 98232-51-0 ]

[ 98232-51-0 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 41214-27-1 ]
  • [ 98232-51-0 ]
YieldReaction ConditionsOperation in experiment
73% With PPA In chlorobenzene at 80℃; for 15 h; The solution of PPA in chlor-benzene was added Compound Int-19d (22 g, 0.1 mol) at 80 °C and the mixture was allowed to stir at 80 °C for about 15 hours. The solution was removed and the residue was dissolved in ethyl acetate and washed with NaOH (IN, aqueous) followed by brine. The organic layer was dried over Na2S04, filtered and concentrated in vacuo to provide Compound Int-19e (14 g, 73 percent). 1H NMR (CDC13) 6: 7.74 (d, J= 8 Hz, 1 H), 6.63 (d, J= 8 Hz, 1 H), 6.53 (s, 1 H), 4.21 (t, J= 12 Hz, 2 H), 3.80 (s, 3 H), 2.84 (t, J - 16 Hz, 2 H), 2.18 - 2.15 (m, 2H).
Reference: [1] Patent: WO2012/50848, 2012, A1, . Location in patent: Page/Page column 109-110
[2] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 23, p. 5025 - 5033
[3] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 21, p. 9554 - 9573
[4] Justus Liebigs Annalen der Chemie, 1954, vol. 587, p. 38,47
[5] Synthetic Communications, 2009, vol. 39, # 15, p. 2664 - 2673
[6] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 18, p. 5436 - 5441
[7] Journal of Medicinal Chemistry, 2018, vol. 61, # 2, p. 514 - 534
  • 2
  • [ 150-19-6 ]
  • [ 98232-51-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 23, p. 5025 - 5033
[2] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 18, p. 5436 - 5441
[3] Patent: WO2012/50848, 2012, A1,
  • 3
  • [ 57052-73-0 ]
  • [ 98232-51-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 23, p. 5025 - 5033
[2] Patent: WO2012/50848, 2012, A1,
  • 4
  • [ 3245-40-7 ]
  • [ 98232-51-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 23, p. 5025 - 5033
  • 5
  • [ 651027-16-6 ]
  • [ 98232-51-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 23, p. 5025 - 5033
  • 6
  • [ 552-41-0 ]
  • [ 98232-51-0 ]
Reference: [1] Canadian Journal of Chemistry, 2004, vol. 82, # 5, p. 571 - 578
  • 7
  • [ 41214-27-1 ]
  • [ 98232-51-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1989, vol. 26, p. 1547 - 1554
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 98232-51-0 ]

Ethers

Chemical Structure| 42327-52-6

[ 42327-52-6 ]

7-Methoxychroman-4-one

Similarity: 0.94

Chemical Structure| 5802-17-5

[ 5802-17-5 ]

6-Methoxychroman-4-one

Similarity: 0.92

Chemical Structure| 54107-66-3

[ 54107-66-3 ]

5,7-Dimethoxychroman-4-one

Similarity: 0.91

Chemical Structure| 1157-39-7

[ 1157-39-7 ]

4',7-Dimethoxyisoflavone

Similarity: 0.89

Chemical Structure| 131-57-7

[ 131-57-7 ]

(2-Hydroxy-4-methoxyphenyl)(phenyl)methanone

Similarity: 0.88

Ketones

Chemical Structure| 42327-52-6

[ 42327-52-6 ]

7-Methoxychroman-4-one

Similarity: 0.94

Chemical Structure| 491-37-2

[ 491-37-2 ]

4-Chromanone

Similarity: 0.92

Chemical Structure| 80096-64-6

[ 80096-64-6 ]

6-Hydroxy-chroman-4-one

Similarity: 0.92

Chemical Structure| 5802-17-5

[ 5802-17-5 ]

6-Methoxychroman-4-one

Similarity: 0.92

Chemical Structure| 39513-75-2

[ 39513-75-2 ]

6-Methylchroman-4-one

Similarity: 0.92

Related Parent Nucleus of
[ 98232-51-0 ]

Other Aromatic Heterocycles

Chemical Structure| 42327-52-6

[ 42327-52-6 ]

7-Methoxychroman-4-one

Similarity: 0.94

Chemical Structure| 491-37-2

[ 491-37-2 ]

4-Chromanone

Similarity: 0.92

Chemical Structure| 80096-64-6

[ 80096-64-6 ]

6-Hydroxy-chroman-4-one

Similarity: 0.92

Chemical Structure| 5802-17-5

[ 5802-17-5 ]

6-Methoxychroman-4-one

Similarity: 0.92

Chemical Structure| 39513-75-2

[ 39513-75-2 ]

6-Methylchroman-4-one

Similarity: 0.92